Dizal’s ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer
SHANGHAI, May 27, 2026 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of oncology and hematological diseases, announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has accepted and granted priority review to the New Drug Application (NDA) for...
Announcement of The Shaw Laureates 2026
HONG KONG, May 27, 2026 /PRNewswire/ -- The Shaw Prize in Astronomy is awarded in equal shares to Ken'ichi NomotoEmeritus Professor and Visiting Senior Scientist of the Kavli Institute for the Physics and Mathematics of the Universe, University of Tokyo, Japan and Stanford WoosleyProfessor of Astronomy and Astrophysics, University of California, Santa...
WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities
SHANGHAI, May 27, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Drug Product Facility 15 (DP15), located at the company's Fengxian site in Shanghai, achieved GMP release in April. The facility has since progressed seamlessly into operation, completing multiple engineering and GMP batches, delivering clinical supplies to support...
CGBIO Signs Global Clinical and Exclusive Commercialization Agreement for NOVOSIS in the U.S., Canada and Australia
DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development and regulatory approvals, including FDA IDE and PMA pathways Full-scale entry into North America, the world's largest bone graft substitute market; strategic partnership to expand in orthopaedics and bone regeneration sectors ...
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs CordenPharma has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide CDMO with facilities in North Augusta, South Carolina (USA) and Shanghai (China). With the acquisition, CordenPharma broadens its peptide API development and manufacturing capabilities for complex peptide programs. The transaction expands CordenPharma's upstream and...
Big Jump SEO Partners with Two Leading Local Health Platforms to Pioneer Gemini AI Integration, Elevating the Quality of Medical and Wellness Content
HONG KONG, May 27, 2026 /PRNewswire/ -- Big Jump SEO Solutions, a leading digital marketing and Search Engine Optimization (SEO) expert, today officially announced a strategic partnership with two of Hong Kong's prominent health and medical platforms: HealthHK101 and HealthyCheckHK. This collaboration marks the debut integration of Google's latest-generation Gemini AI technology, aimed at optimizing and reshaping online medical...
Vastnaut Wraps Up Its First Los Angeles Demo Day, Letting Supporters Live-Test the 4×4 Exoskeleton
LOS ANGELES, May 26, 2026 /PRNewswire/ -- Vastnaut, a pioneering wearable robotics startup, today announced the successful conclusion of its three-day Demo Day in Beverly Hills, Los Angeles (May 21-23). In an unprecedented move for the consumer exoskeleton category, Vastnaut broke away from usual crowdfunding practices by inviting outdoor explorers, everyday users, and passersby to physically test Vastnaut One—the world's...
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
Cambridge, Mass., May 26, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Human Life Foundation Models, Inc. (HLFM), a newly launched company established by Human Longevity, Inc. today announced a multi-million-dollar AI co-development collaboration to build industry's first large-scale foundation models dedicated to human longevity science. As aging populations reshape global...
Doceree, Healthcare Marketing’s AI-Powered Operating System, Earns Frost & Sullivan’s 2026 Global Technology Innovation Leadership Recognition
Doceree is recognized as the AI leader in healthcare marketing for unifying the full prescription journey — from physician awareness to fill — on a single, clinically intelligent operating system. SAN ANTONIO, May 26, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Doceree has been awarded the 2026 Global Technology Innovation Leadership Recognition in the AI-powered...
Neurophet Launches Joint Study with VHIR on ‘Neurophet AQUA MS’, Accelerating AI Algorithm Validation
Collaborative research on AI-based diagnosis of multiple sclerosis, Building a clinical trial dataset Leveraging large-scale, multi-center brain MRI datasets to detect key lesion biomarkers SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis...
